We understand the rigor needed to demonstrate that new products are in fact less harmful than cigarettes. Our scientists span various disciplines and share the common goal of tobacco harm reduction.
To support our scientific efforts, we established a rigorous scientific framework based on the FDA's guidance to evaluate potentially reduced-harm tobacco products.
Our scientific approach focuses on:
- measuring harmful and potentially harmful compounds;
- evaluating the product's health effects;
- researching how adult tobacco consumers use the product and their understanding of its risk; and
- substantiating that the product is unlikely to appeal to unintended audiences.
We share the results of our scientific studies with the FDA and others through peer-reviewed journals, conference presentations, one-on-one meetings, and on a website
designed for scientists, public health and regulatory experts to review the science.